Evidence map›Paper›PMID 39064483›Full record

Observational studyMedicina (Kaunas, Lithuania)2024

The Value of Preoperative C-Reactive Protein to Albumin Ratio as a Prognostic Biomarker in Colon Cancer Patients.

Giorgiana Fagarasan, Radu Seicean, Vasile Bintintan, Vlad Fagarasan, Alexandra Caziuc, David Andras, Lucian Chira, George Dindelegan

Abstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giorgiana FagarasanFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.
Radu SeiceanFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.
Vasile BintintanFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.
Vlad FagarasanFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.ORCID 0000-0001-8425-8399
Alexandra CaziucFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.ORCID 0000-0001-7591-4059
David AndrasFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.ORCID 0000-0002-8705-9181
Lucian ChiraFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.ORCID 0000-0003-1028-0803
George DindeleganFirst Surgical Clinic, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.ORCID 0000-0003-1485-6654

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory acute phase proteins have been reported to play a crucial role in cancer progression. Various hematologic and inflammatory markers and scores, such as the lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic inflammation score (SIS), prognostic nutritional index (PNI), Glasgow prognostic score, and, more recently, the Naples prognostic score, have been reported as significant prognostic markers. The aim of this prospective study was to evaluate the prognostic significance of the C reactive protein-to-albumin ratio (CAR) in patients with colon cancer.

Indexed as

Colonic NeoplasmsC-Reactive ProteinAdultAgedAged, 80 and overBiomarkers, TumorFemaleHumansMaleMiddle AgedPreoperative PeriodPrognosisProspective StudiesROC CurveSerum AlbuminBiomarkers, TumorC-Reactive ProteinSerum Albumincolon cancerC-reactive protein to albumin ratioprognosis

Identifiers

PMID39064483
PMCPMC11278571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.